Chorioretinal Alterations Induced by Preeclampsia

He, Xinyi; Ji, Yimei; Yu, Meiting; Tong, Yuhua

doi:https://doi.org/10.1155/2021/8847001

Journal of Ophthalmology

On this page

Abstract Introduction Methods Conclusion Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2021 | Article ID 8847001 | https://doi.org/10.1155/2021/8847001

Chorioretinal Alterations Induced by Preeclampsia

Xinyi He,^1,2Yimei Ji,³Meiting Yu,²and Yuhua Tong²

Academic Editor: Akio Oishi

Received15 Sept 2020

Revised22 Feb 2021

Accepted03 Mar 2021

Published10 Mar 2021

Abstract

Hypertension during pregnancy, which is essentially a microvascular disease that destroys the end-organ microcirculation, should not be underestimated, as it could lead to organ failure in the kidneys, lungs, and brain. Preassessment of the microcirculatory state through systematic observation of the fundus has been proven to be noninvasive and feasible. Although hypertension in preeclampsia patients will resolve after childbirth, the sticking point is determining the best termination moment. Early diagnosis and treatment can prevent long-term ocular complications and cardiovascular risks for pregnant women in the future. In order to adjust the treatment strategy through more sensitive and precise fundus changes, we comprehensively summarized the common structural changes in the fundus in preeclampsia patients, including changes in the blood vessels, choroid, and retina, as well as the application of quantitative observation for chorioretinal alterations in recent years.

1. Introduction

Hypertensive disease in pregnancy, the most common disease worldwide, is responsible for significant morbidity and mortality for both mothers and children. The clinical syndrome is ascribed to maternal systemic microvascular disturbance, which affects all organs throughout the body.

One of the organs affected is the eyes. The disease can generate ocular alterations affecting the conjunctiva, choroid, and retina [1]. The choroid is one of the most vascularized tissues in the human body, whose distinctive role is to supply oxygen and nutrients to the outer retina. Consequently, chorioretinal changes can be affected by the microcirculation. Once the choroid blood supply is impaired, the retina will also suffer a corresponding disorder.

Complex interactions exist between the ocular impact on preeclampsia (PE) and how ocular dysfunction changes the process of pregnancy.

The aim of this study was to review the current literature concerned with fundus alterations in PE. The following paragraphs will systematically introduce PE, the anatomy and physiology of the fundus, how PE changes the fundus, vascular changes in the retina, hypertensive choroidopathy, and hypertensive retinopathy.

2. Methods

The related literature was searched from 2000 to 2020 in PubMed and the Web of Science database. The search strategy was based on a combination of terms: (1) “pre-eclampsia” or “preeclampsia” or “pregnancy toxemias;” (2) “diseases, retinal” or “retinal disease” or “retinopathy;” (3) “choroid” or “choriocapillaris” or “choroid disease.” The duplicate articles were removed.

2.1. PE

PE is a multisystemic disorder that is defined as new-onset hypertension and proteinuria during pregnancy after 20 weeks. However, according to the literature, patients with or without proteinuria seem to be untreatable if there is evidence of systemic involvement, such as thrombocytopenia, renal insufficiency, or pulmonary edema [2]. Moreover, compared with women without proteinuria, women with proteinuria are at greater risk of severe hypertension and of delivering premature babies or babies younger than their gestation period [3].

PE can deteriorate rapidly without any warning and is closely related to the prognosis of the mother and fetus. Sixteen percent of maternal deaths worldwide can be attributed to hypertension, resulting in more than 70000 maternal and over 500000 fetal and neonatal deaths each year [4]. Risk factors include maternal age, multiple pregnancies, childbirth, and the history of complicated systemic diseases.

The etiology and pathogenetic mechanisms of PE remain controversial. Numerous factors give rise to gestational hypertension, including heredity, hypoxia, trophoblast invasion, oxidative stress, and intravascular inflammation. However, it is generally accepted that the disease originates from reduced placental perfusion, which leads to abnormal vascular remodeling and maternal vascular endothelial dysfunction resulting in multiple organ failure in PE [1, 5–11].

The short-term complications of PE include cerebrovascular accidents, acute renal failure, and even maternal death. Previous literature indicates that long-term risks and mortality are increasing in women with PE [12, 13]. Further research is needed to advance the current knowledge to decrease the incidence of adverse perinatal outcomes, including fetal growth restriction and stillbirth.

2.2. Anatomy and Physiology of the Fundus

The retina has a dual blood delivery system: the central retinal artery (CRA) is the terminal vasculum, which mainly supplies the inner five layers of the retina; the other is the choroidal vascular system, which serves the outer five layers, and is composed of the two main posterior ciliary arteries (PCAs), namely, the medial and lateral PCA.

The choroid is mainly a vascular network that nourishes the eyeball and regulates blood volume. Traditionally, the choroid is viewed as vascularized tissue that comprises several vascular layers. Judging by the vascular thickness and density, from inside to outside, they are defined as the Haller layer, Sattler layer, and capillary layer, respectively. The Haller layer contains thick choroidal vessels, while the Sattler layer contains medium-sized blood vessels. The choroid provides oxygen and nutrients for the retinal pigment epithelium (RPE), outer retina, optic nerve, and avascular fovea. Other functions probably include light absorption, heat dissipation to regulate body temperature, and blood flow control through vasomotor and intraocular pressure (IOP).

2.3. How PE Changes the Fundus

The retina shows no physiological or visible changes in the fundus during normal pregnancy. However, almost all pregnant women have reactive changes in the retinal arterioles; one study showed that significant changes occurred only during PE or eclampsia seizures [14].

PE is routinely considered to be a vascular disorder. Hypertension in pregnancy exerts a striking effect on capillaries flowing through the organs. Studies have stated that 40–100% of PE pregnancies have retinal vascular abnormalities, which are regarded as indicators of termination of the pregnancy. Some potent endothelium-derived vasoconstrictors produced by the maternal placenta may induce severe spasms in the vessels of the brain, spleen, kidneys, and lungs. Due to the upregulation of the sympathetic nervous system in PE, the retinal blood vessels are not dominated by sympathetic nerves. Therefore, observations of the fundus have become an ideal choice for the direct and objective assessment of systemic microvascular changes during pregnancy.

Some studies have reported that choroidal ischemia and retinal circulation disorders are present in 30–100% of PE patients [15]. Choroidal perfusion is highly sensitive to abnormalities in systemic blood flow and perfusion. Hemodynamic changes during pregnancy may provoke pregnancy-related fluid retention in the choroidal layer, leading to increases in choroidal thickness. However, PE is often accompanied by systemic vasospasm. The main arterioles of the eye contract and spasm, including the PCAs and the CRA, result in a corresponding decrease in the choroidal blood supply. Moreover, systemic vascular resistance, including in the choroidal vessels, is increased in PE patients, which critically reduces choroidal vascular perfusion and presents a thinner choroid than that in healthy pregnancy patients.

The normal function of the retina depends on the normal morphological structure of the choroid. Once damage occurs in the RPE and blood-retinal barrier, protein and fluid leakage into the retinal neuroepithelial layer is inevitable, which ultimately causes retinal exudation, edema, and detachment. In addition, if the arterioles suffer hypoxia to a certain degree, arteriosclerosis is progressively promoted, which aggravates the interruption of blood flow, leading to the eventual occurrence of retinal hypoxic ischemic necrosis. The increased permeability in the hardened arterioles is the original cause of retinal bleeding, exudation, edema, and even retinal detachment in some severe cases. The chorioretinal abnormalities caused by PE mainly include segmental and generalized arterial stenosis, choroidal vascular network ischemia, retinal bleeding, central serous chorioretinopathy (CSC), and serous retinal detachment (SRD).

2.4. Vascular Changes in the Retina

Retinal vascular abnormalities caused by PE are similar to those in chronic hypertensive retinopathy. The most common retinal abnormalities are focal arteriole spasm and narrowing. Ophthalmological evaluations of PE patients have been mostly obtained through fundoscopy. Fundus photography mainly captures evident and visible retinal alterations, such as artery stenosis, for obstetric treatment and intervention. However, direct fundoscopy has proven to be unreliable due to its subjectivity, with a high rate of variation between observers (20–40%) and by the observers themselves (10–33%) [16, 17].

A genome-wide linkage analysis from the Beaver Dam Eye Study established a relationship between the diameter of retinal arterioles and multiple gene loci that are linked with the regulation of blood pressure, endothelial function, and angiogenesis [18], which suggests that retinal arteriole stenosis may be a surrogate marker of the individual genetic predisposition to hypertension [19, 20]. Ramos found that novel vascular interstitial cells (VICs) exist between endothelial and smooth muscle cells, allowing these cells to sense changes in vascular tension [21]. VICs have the ability to synthesize nitric oxide (NO), potentially due to its NADPH-diaphorase activity, thereby involving them in the regulation of blood pressure and local blood flow. Generally, VICs exert sphincter-like activities during hypertension to adjust retinal blood flow.

When the lesion becomes macroscopically visible, an irreversible loss of pathological structure and function has occurred. Therefore, highly sensitive technology is needed in the diagnosis and prognosis of chorioretinal disorders in pregnant women. Studies have found that there is a strong correlation between the retinal microvessel caliber and hypertension [22–24]. Applying digital retinal photography and imaging software, Wong et al. [22] measured the width of the retinal vessels to objectively quantify extensive arteriole stenosis. In 838 binocular retinal vessel images, they found that the increase in blood pressure was significantly negatively correlated with the diameter of the retinal arterioles. For every 10 mmHg increase in the mean arterial blood pressure, the mean diameter of small arteries in both the eyes decreased by 4.0 μm. Von Hanno et al. [23] and Lee et al. [25] also viewed the mean arterial pressure as the main factor causing changes in the diameter of the retinal arterioles and venules. This reveals that acute hypoxia and ischemia owing to hypertension have a significant impact on microcirculation and retinal thickness and that there is a correlation between microcirculation and retinal thickness. Additionally, the severity of vessel abnormalities is positively correlated with blood pressure. The higher the blood pressure, the more apparent the alterations and the more severe the degree of retinopathy [26, 27]. Kaliaperuma et al. [26] observed that diastolic blood pressure has a significant positive correlation with retinopathy in severe preeclampsia (sPE) patients. A cross-sectional study in Singapore discovered that for every 10 mmHg increase in mean arterial pressure during pregnancy, the caliber of small retinal arteries was significantly reduced [28].

2.5. Hypertensive Choroidopathy

The choroid is the corresponding part of the eye that undergoes ischemia in microcirculation disorders in PE. The manifestations of choroidal ischemia generally precede abnormalities of the retinal microvessels. Prior studies identified the presence of HLA class I self-peptides, ICAM-1, and carbonic anhydrase 4 (CA4) in the choriocapillaris, which serves as a regulator of the metabolic and inflammatory environment in the choroid and its supporting tissues [29–31]. As the innermost vascular network, the choriocapillaris provides oxygen and nutrients to the outer retina. Compared with other capillaries, those in the choriocapillaris have a larger lumen diameter. There are circular openings on the capillaries, which are covered by diaphragms, mainly participating in material exchange through subcellular endothelial structures, such as pits, transendothelial channels, window openings, and intercellular connections for material exchange [32, 33]. However, how the choriocapillaris maintains perforated endothelial cells remains unknown, as the subretinal space is generally the only potential space. Once the vascular endothelial cells of the choroid are affected by systemic hemodynamics, the RPE of the outer retina is damaged. The RPE is the transmission channel between the choroid and the photoreceptor cells. A reduced blood supply means hypoxia of photoreceptor cells and visual impairment. Moreover, the RPE has the ability to maintain the homeostasis of the subretinal space [34, 35]. Therefore, the choroid plays an essential role in the proper functioning of the retina.

Fluorescein angiography (FA) and indocyanine green angiography (ICGA) have previously been used to assess choroidal function during pregnancy in PE patients [36–38]. As early as 1980, Mabie and Ober [36] found that FA in PE patients showed delayed choroidal capillary filling. Fastenberg et al. [39], Sathish and Arnold [40], and Hage et al. [41] recorded the changes in angiographs in patients with SRD combined with PE, showing delayed perfusion of the choroidal capillaries, nonperfusion areas, and late slow fluorescein leakage between the subretinal and pigmented epithelial spaces. The above studies suggest that severe impairment of the choroidal vasculature triggers destruction of the blood-retinal barrier, leading to SRD. Despite the fact that angiography is the gold standard for diagnosis, it has not been widely performed in pregnant women due to its invasiveness.

Scholars have carried out related research on pregnant women with PE for quantitative and qualitative analyses of choroid thickness and choriocapillaris flow. The characteristics of the included studies are shown in Table 1. A meta-analysis of 1227 pregnant women demonstrated that the choroidal thickness of the normal pregnancy group was significantly higher than that of the nonpregnant group [42]. It was speculated that this may be related to the increasing circulating volume or alterations in hormone levels during pregnancy. The choroidal thickness of PE pregnant women and healthy pregnant women is compared in several studies by optical coherence tomography (OCT) [43–45]. Researchers found that the choroid thickness of PE women was thinner than that of healthy pregnant women. The area of choroidal capillary flow in the PE group was lower than that of healthy pregnant women, which is likely related to the vascular tissue edema caused by choroidal hyperperfusion or to vasospasm, where the placenta is invaded, but this needs to be confirmed. However, Kim et al. [46] and Benefica et al. [47] found that the choroid of patients with PE was significantly thicker than that of nonpregnant and healthy pregnant women. The choroidal thickness of patients with sPE was the highest. Considering that both studies only screened patients with sPE before labor, if the vessels are severely contracted, microvascular ischemia and hypoxia of the whole body will exacerbate choroidal permeability. Therefore, further research is needed to confirm whether there is a significant difference in choroidal thickness between PE and healthy pregnant women. Using optical coherence tomography angiography (OCTA) to quantitatively monitor choriocapillaris flow has gained popularity in recent studies. Chanwimol et al. [48] found that the choriocapillaris flow was not significantly different between pregnant women and nonpregnant women. However, Urfalıoglu [49] analyzed the choriocapillaris flow area (CBPA) in PE pregnant women, healthy pregnant women, and control nonpregnant women. The outcome indicated that CBPA was higher in both groups of pregnant women than in the control group of nonpregnant women. Currently, the quantitative analysis in the choroidal vascular network remains limited, but it has critical significance for the basic graded diagnosis and treatment of pregnant women.

2.6. Hypertensive Retinopathy

The retinal thickness and total macular volume of healthy pregnant women increases significantly in the second and third trimesters [50, 51], which may be ascribed to the increased blood flow and pregnancy-related fluid retention. The included studies of retinal parameters in PE patients are shown in Table 2. Neudorfer et al. [52] stated that the average thickness of the retinal nerve fiber layer (RNFL) around the optic disc was greater in patients with PE. They speculated that the thickening of the RNFL in patients with PE may be because the central nervous system is also involved in pathophysiological changes. The latest study showed that the thickness of the RNFL around the optic disc was higher in the group of women with PE and the group of healthy pregnant women than in the control group [53].

However, other scholars believe that acute severe hypoxic injury of the PE system may change the microcirculation, leading to a permanent reduction in retinal thickness [54, 55]. Kara et al. [56] stated that the RNFL thickness of PE patients was lower than that of normal pregnant women. Arab et al. [57] found that women with sPE or eclampsia had the greatest decrease in the average RNFL thickness around the optic disc. Therefore, it can be inferred that elevated blood pressure causes irreversible damage to the microstructure of the retina, even though there are no obvious clinical macroscopic symptoms. The expression of the tumor necrosis factor (TNF-α) and vascular endothelial growth factor (VEGF) is upregulated in the retina of PE patients [58, 59]. As an effective molecule of inflammation, angiogenesis, and apoptosis, TNF-α induces a series of pathophysiological changes, such as injury and apoptosis of endothelial and retinal cells, angiogenesis, and vascular leakage, by producing VEGF [60]. Angiotensin II (Ang II) also stimulates endothelial cells to generate VEGF, which has been confirmed to exist in the retina [61]. VEGF is an essential cellular molecule involved in the occurrence of retinal vascular disorders. By motivating the tyrosine kinase receptors VEGFR1 and VEGFR2, VEGF changes the extracellular matrix, destroys the endothelial blood-retinal barrier, promotes the differentiation, proliferation, and migration of endothelial cells, and ultimately, causes retinal impairment.

Saito et al. [62] first used OCTA to observe the retina in PE patients. Newman et al. [53] included 98 pregnant women: 55 in the PE group and 43 in the healthy pregnant group. The data suggested that the superficial foveal density (SFD) and deep foveal density (DFD) of PE patients were lower than those of normal pregnant women, and the DFD was lower than the SFD. There was no significant difference in the foveal avascular zone (FAZ). Urfalioglu et al. [49] found that the area of blood vessels around the optic nerve was significantly reduced compared with that of the control group, reflecting the lack of substantial blood flow around the optic nerve in PE patients. This may be related to the mechanism of hypoperfusion or vasoconstriction generated by hyperperfusion injury. The authors also believe that the self-regulation ability of the optic nerve regarding peripheral circulation is weaker than that of the retinal arterioles and that it responds more strongly to the influence of systemic blood pressure fluctuations. Due to the sample size limitations of the abovementioned studies and patient inclusion criteria, there was no visible retinopathy. Consequently, whether the measurements of the SFD, DFD, and FAZ vary with the severity of the disease remains to be confirmed.

2.7. SRD

SRD is a complication of PE, first proposed by von Graefe in 1855. SRD occurs in 1% of PE patients and approximately 10% of eclampsia patients. Most scholars believe that SRD is attributed to choroidal ischemia. When edema and necrosis of the RPE develop, the outer blood-retinal barrier is destroyed, causing choroidal leakage under the retina and forming a serous separation. SRD complicated with PE is mostly reported in the form of case reports [47, 63]. Altalbishi et al. [63] not only reported a case of a pregnant woman with limited SRD but also summarized the fundus changes in PE patients after secondary SRD. The visual prognosis with retinal detachment secondary to PE is usually good, but irreversible tissue damage and necrosis can still occur in the outer retinal and choroidal layers. Therefore, timely diagnosis and intervention cannot be neglected.

2.8. CSC

It is well known that pregnancy is one of the risk factors for CSC. Compared with that of patients with normal blood pressure, the vascular system of PE patients includes increased systemic vascular permeability. Choroidal ischemia impairs the RPE function of fluid transport. In addition, subretinal fluid accumulates due to increasing choroidal vascular permeability, accounting for serous nerve sensory detachment. There are few reports describing the prevalence of CSC in women with PE [27, 37, 64]. In a retrospective observational study of 1881 Japanese women, it was believed that the risk of CSC in PE pregnant women was greater in normal pregnancies, especially in women with blood concentrations that were considered to be associated with a higher CSC risk [65].

3. Conclusion

The fundus changes in PE patients mentioned above are usually reversible, and the symptoms can be relieved and recovered after termination of the pregnancy or childbirth; but clinically, approximately 1/3 of patients have ocular sequelae [66, 67]. There is conclusive evidence that retinopathy is essential for the prognosis of future cardiovascular events.

Conclusively, fundus alterations in PE are closely related to the disease progression. With advancements in technology and equipment, screening of the eye has become increasingly refined, and the study of structural changes of the fundus, including changes affecting the blood vessels, choroid, and retina, has become the mainstream. However, through the above findings, most of the existing literature is limited to the study of the choroid, and research on the macula, optical disc, and retina needs to be further developed and perfected. Measuring quantitative alterations can be used to prevent severe complications and predict the risk of future hypertension in PE patients, which provide good guidance for the early prevention of the disease. Therefore, the microscopic measurement of fundus data and quantification of the correlation with PE have become the target direction of our next phase of research.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

He X.Y. collected the literature and wrote the manuscript. Ji Y.M. helped to collect the literature and reviewed the manuscript. Yu M.T. helped to collect the literature. Tong Y.H. made suggestions and reviewed the manuscript.

Acknowledgments

This study was supported by the Zhejiang Provincial Natural Science Foundation of China (no. GF18H120003).

References

J. P. Granger, B. T. Alexander, M. T. Llinas, W. A. Bennett, and R. A. Khalil, “Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction,” Microcirculation, vol. 9, no. 3, pp. 147–160, 2002.
View at: Publisher Site | Google Scholar
American College of Obstetricians and Gynecologists, “Hypertension in pregnancy. report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy,” Obstetrics and Gynecology, vol. 122, no. 5, pp. 1122–1131, 2013.
View at: Publisher Site | Google Scholar
T. Chaiworapongsa, P. Chaemsaithong, L. Yeo, and R. Romero, “Pre-eclampsia part 1: current understanding of its pathophysiology,” Nature Reviews Nephrology, vol. 10, no. 8, pp. 466–480, 2014.
View at: Publisher Site | Google Scholar
K. S. Khan, D. Wojdyla, L. Say, A. M. Gülmezoglu, and P. F. Van Look, “WHO analysis of causes of maternal death: a systematic review,” The Lancet, vol. 367, no. 9516, pp. 1066–1074, 2006.
View at: Publisher Site | Google Scholar
J. M. Roberts and H. S. Gammill, “Preeclampsia: recent insights,” Hypertension, vol. 46, no. 6, pp. 1243–1249, 2005.
View at: Publisher Site | Google Scholar
J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger, “Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 294, no. 2, pp. H541–H550, 2008.
View at: Publisher Site | Google Scholar
J. P. Granger, B. T. Alexander, W. A. Bennett, and R. A. Khalil, “Pathophysiology of pregnancy-induced hypertension,” American Journal of Hypertension, vol. 14, no. 6, pp. 178S–185S, 2001.
View at: Publisher Site | Google Scholar
M. Noris, N. Perico, and G. Remuzzi, “Mechanisms of disease: pre-eclampsia,” Nature Clinical Practice Nephrology, vol. 1, no. 2, pp. 98–114, 2005.
View at: Publisher Site | Google Scholar
C. W. Redman and I. L. Sargent, “Latest advances in understanding preeclampsia,” Science, vol. 308, no. 5728, pp. 1592–1594, 2005.
View at: Publisher Site | Google Scholar
B. Sibai, G. Dekker, and M. Kupferminc, “Pre-eclampsia,” The Lancet, vol. 365, no. 9461, pp. 785–799, 2005.
View at: Publisher Site | Google Scholar
S. Sankaralingam, I. A. Arenas, M. M. Lalu, and S. T. Davidge, “Preeclampsia: current understanding of the molecular basis of vascular dysfunction,” Expert Reviews in Molecular Medicine, vol. 8, no. 3, pp. 1–20, 2006.
View at: Publisher Site | Google Scholar
M. L. Mongraw-Chaffin, P. M. Cirillo, and B. A. Cohn, “Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort,” Hypertension, vol. 56, no. 1, pp. 166–171, 2010.
View at: Publisher Site | Google Scholar
J. G. Ray, M. J. Vermeulen, M. J. Schull, and D. A. Redelmeier, “Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study,” The Lancet, vol. 366, no. 9499, pp. 1797–1803, 2005.
View at: Publisher Site | Google Scholar
F. Mackensen, W. E. Paulus, R. Max et al., “Ocular changes during pregnancy,” Deutsches Aerzteblatt International, vol. 111, no. 33-34, pp. 567–575, 2014.
View at: Publisher Site | Google Scholar
B. P. Sheth and W. F. Mieler, “Ocular complications of pregnancy,” Current Opinion in Ophthalmology, vol. 12, no. 6, pp. 455–463, 2001.
View at: Publisher Site | Google Scholar
S. B. Dimmitt, S. M. Eames, P. Gosling, J. N. W. West, J. M. Gibson, and W. A. Littler, “Usefulness of ophthalmoscopy in mild to moderate hypertension,” The Lancet, vol. 333, no. 8647, pp. 1103–1106, 1989.
View at: Publisher Site | Google Scholar
M. V. Lehmann and R. E. Schmieder, “Remodeling of retinal small arteries in hypertension,” American Journal of Hypertension, vol. 24, no. 12, pp. 1267–1273, 2011.
View at: Publisher Site | Google Scholar
C. Xing, B. E. Klein, R. Klein, G. Jun, K. E. Lee, and S. K. Iyengar, “Genome-wide linkage study of retinal vessel diameters in the beaver dam eye study,” Hypertension, vol. 47, no. 4, pp. 797–802, 2006.
View at: Publisher Site | Google Scholar
C. Y. Cheung, M. K. Ikram, C. Sabanayagam, and T. Y. Wong, “Retinal microvasculature as a model to study the manifestations of hypertension,” Hypertension, vol. 60, no. 5, pp. 1094–1103, 2012.
View at: Publisher Site | Google Scholar
J. J. Wang and T. Y. Wong, “Genetic determinants of retinal vascular caliber: additional insights into hypertension pathogenesis,” Hypertension, vol. 47, no. 4, pp. 644-645, 2006.
View at: Publisher Site | Google Scholar
D. Ramos, J. Catita, M. López-Luppo et al., “Vascular interstitial cells in retinal arteriolar annuli are altered during hypertension,” Investigative Opthalmology & Visual Science, vol. 60, no. 2, pp. 473–487, 2019.
View at: Publisher Site | Google Scholar
T. Wong, M. D. Knudtson, R. Klein, B. E. Klein, S. M. Meuer, and L. D. Hubbard, “Computer-assisted measurement of retinal vessel diameters in the Beaver dam eye study: methodology, correlation between eyes, and effect of refractive errors,” Ophthalmology, vol. 111, no. 6, pp. 1183–1190, 2004.
View at: Publisher Site | Google Scholar
T. Von Hanno, G. Bertelsen, A. K. Sjølie, and E. B. Mathiesen, “Retinal vascular calibres are significantly associated with cardiovascular risk factors: the Tromsø eye study,” Acta Ophthalmologica, vol. 92, no. 1, pp. 40–46, 2014.
View at: Publisher Site | Google Scholar
M. K. Ikram, Y. T. Ong, C. Y. Cheung, and T. Y. Wong, “Retinal vascular caliber measurements: clinical significance, current knowledge and future perspectives,” Ophthalmologica, vol. 229, no. 3, pp. 125–136, 2013.
View at: Publisher Site | Google Scholar
W. H. Lee, J. H. Park, Y. Won et al., “Retinal microvascular change in hypertension as measured by optical coherence tomography angiography,” Scientific Reports, vol. 9, no. 1, p. 156, 2019.
View at: Publisher Site | Google Scholar
S. Kaliaperumal, S. Setia, A. Gupta, and V. A. Rao, “Fetal birthweight and diastolic blood pressure: association with retinopathy in severe preeclampsia,” European Journal of Ophthalmology, vol. 18, no. 5, pp. 809–812, 2008.
View at: Publisher Site | Google Scholar
G. M. Somfai, K. Miháltz, E. Tulassay et al., “Diagnosis of serous neuroretinal detachments of the macula in severe preeclamptic patients with optical coherence tomography,” Hypertension in Pregnancy, vol. 25, no. 1, pp. 11–20, 2006.
View at: Publisher Site | Google Scholar
L. J. Li, C. Y. Cheung, M. K. Ikram et al., “Blood pressure and retinal microvascular characteristics during pregnancy: growing up in Singapore towards healthy outcomes (GUSTO) study,” Hypertension, vol. 60, no. 1, pp. 223–230, 2012.
View at: Publisher Site | Google Scholar
D. Abi-Hanna, D. Wakefield, and S. Watkins, “HLA antigens in ocular tissues I. in vivo expression in human eyes,” Transplantation, vol. 45, no. 3, pp. 610–613, 1988.
View at: Publisher Site | Google Scholar
G. S. Hageman, X. L. Zhu, A. Waheed, and W. S. Sly, “Localization of carbonic anhydrase IV in a specific capillary bed of the human eye,” Proceedings of the National Academy of Sciences, vol. 88, no. 7, pp. 2716–2720, 1991.
View at: Publisher Site | Google Scholar
R. F. Mullins, J. M. Skeie, E. A. Malone, and M. H. Kuehn, “Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina,” Molecular Vision, vol. 12, pp. 224–235, 2006.
View at: Google Scholar
D. L. Nickla and J. Wallman, “The multifunctional choroid,” Progress in Retinal and Eye Research, vol. 29, no. 2, pp. 144–168, 2010.
View at: Publisher Site | Google Scholar
S. A. Kim, S. J. Kim, Y. A. Choi, H.-J. Yoon, A. Kim, and J. Lee, “Retinal VEGFA maintains the ultrastructure and function of choriocapillaris by preserving the endothelial PLVAP,” Biochemical and Biophysical Research Communications, vol. 522, no. 1, pp. 240–246, 2020.
View at: Publisher Site | Google Scholar
S. Wimmers, M. Karl, and O. Strauss, “Ion channels in the RPE,” Progress in Retinal and Eye Research, vol. 26, no. 3, pp. 263–301, 2007.
View at: Publisher Site | Google Scholar
N. B. Sørensen, “Subretinal surgery: functional and histological consequences of entry into the subretinal space,” Acta Ophthalmologica, vol. 97, no. 114, pp. 1–23, 2019.
View at: Publisher Site | Google Scholar
W. C. Mabie and R. R. Ober, “Fluorescein angiography in toxaemia of pregnancy,” British Journal of Ophthalmology, vol. 64, no. 9, pp. 666–671, 1980.
View at: Publisher Site | Google Scholar
S. Valluri, D. A. Adelberg, R. S. Curtis, and R. J. Olk, “Diagnostic indocyanine green angiography in preeclampsia,” American Journal of Ophthalmology, vol. 122, no. 5, pp. 672–677, 1996.
View at: Publisher Site | Google Scholar
M. A. Belfort and G. R. Saade, “Retinal vasospasm associated with visual disturbance in preeclampsia: color flow doppler findings,” American Journal of Obstetrics and Gynecology, vol. 169, no. 3, pp. 523–525, 1993.
View at: Publisher Site | Google Scholar
D. M. Fastenberg, C. L. Fetkenhour, C. Earl, and D. E. Shoch, “Choroidal vascular changes in toxemia of pregnancy,” American Journal of Ophthalmology, vol. 89, no. 3, pp. 362–368, 1980.
View at: Publisher Site | Google Scholar
S. Sathish and J. J. Arnold, “Bilateral choroidal ischaemia and serous retinal detachment in pre-eclampsia,” Clinical and Experimental Ophthalmology, vol. 28, no. 5, pp. 387–390, 2000.
View at: Publisher Site | Google Scholar
R. Hage, J. Gouhier, A. Jean-Charles, A. Donnio, and H. Merle, “[Retinal detachment in preeclampsia: a series of three cases],” Journal Francais D’ophtalmologie, vol. 35, no. 10, pp. 824 e821–826, 2012.
View at: Publisher Site | Google Scholar
M.-S. Jiang, X.-L. Xu, T. Yang, F. Li, and X.-D. Zhang, “Comparison of choroidal thickness in preeclamptic, healthy pregnant, and nonpregnant women: a systematic review and meta-analysis,” Ophthalmic Research, vol. 62, no. 1, pp. 1–10, 2019.
View at: Publisher Site | Google Scholar
N. Duru, D. M. Ulusoy, A. Özköse et al., “Choroidal changes in pre-eclampsia during pregnancy and the postpartum period: comparison with healthy pregnancy,” Arquivos Brasileiros de Oftalmologia, vol. 79, no. 3, pp. 143–146, 2016.
View at: Publisher Site | Google Scholar
N. Sayin, N. Kara, D. Pirhan et al., “Subfoveal choroidal thickness in preeclampsia: comparison with normal pregnant and nonpregnant women,” Seminars in Ophthalmology, vol. 29, no. 1, pp. 11–17, 2014.
View at: Publisher Site | Google Scholar
M. Ataş, G. Açmaz, H. Aksoy et al., “Evaluation of the macula, retinal nerve fiber layer and choroid in preeclampsia, healthy pregnant and healthy non-pregnant women using spectral-domain optical coherence tomography,” Hypertension in Pregnancy, vol. 33, no. 3, pp. 299–310, 2014.
View at: Publisher Site | Google Scholar
J. W. Kim, M. H. Park, Y. J. Kim, and Y. T. Kim, “Comparison of subfoveal choroidal thickness in healthy pregnancy and pre-eclampsia,” Eye, vol. 30, no. 3, pp. 349–354, 2016.
View at: Publisher Site | Google Scholar
C. Z. Benfica, T. Zanella, L. B. Farias, M. L. R. Oppermann, L. H. S. Canani, and D. Lavinsky, “Choroidal thickness in preeclampsia measured by spectral-domain optical coherence tomography,” International Ophthalmology, vol. 39, no. 9, pp. 2069–2076, 2019.
View at: Publisher Site | Google Scholar
K. Chanwimol, S. Balasubramanian, M. Nassisi et al., “Retinal vascular changes during pregnancy detected with optical coherence tomography angiography,” Investigative Opthalmology & Visual Science, vol. 60, no. 7, pp. 2726–2732, 2019.
View at: Publisher Site | Google Scholar
S. Urfalıoglu, M. Bakacak, G. Özdemir, M. Güler, A. Beyoglu, and G. Arslan, “Posterior ocular blood flow in preeclamptic patients evaluated with optical coherence tomography angiography,” Pregnancy Hypertension, vol. 17, pp. 203–208, 2019.
View at: Publisher Site | Google Scholar
C. Cankaya, M. Bozkurt, and O. Ulutas, “Total macular volume and foveal retinal thickness alterations in healthy pregnant women,” Seminars in Ophthalmology, vol. 28, no. 2, pp. 103–111, 2013.
View at: Publisher Site | Google Scholar
M. Demir, E. Oba, E. Can et al., “Foveal and parafoveal retinal thickness in healthy pregnant women in their last trimester,” Clinical Ophthalmology, vol. 5, pp. 1397–1400, 2011.
View at: Publisher Site | Google Scholar
M. Neudorfer, O. Spierer, M. Goder et al., “The prevalence of retinal and optical coherence tomography findings in preeclamptic women,” Retina, vol. 34, no. 7, pp. 1376–1383, 2014.
View at: Publisher Site | Google Scholar
E. Newman, N. T. Okcu, and N. Ç. Dogan, “Optical coherence tomography angiography findings in preeclampsia,” Eye, vol. 33, no. 12, pp. 1946–1951, 2019.
View at: Publisher Site | Google Scholar
M. L. Gomez, F. Mojana, D.-U. Bartsch, and W. R. Freeman, “Imaging of long-term retinal damage after resolved cotton wool spots,” Ophthalmology, vol. 116, no. 12, pp. 2407–2414, 2009.
View at: Publisher Site | Google Scholar
J. W. Koh, K. H. Park, M. S. Kim, and J. M. Kim, “Localized retinal nerve fiber layer defects associated with cotton wool spots,” Japanese Journal of Ophthalmology, vol. 54, no. 4, pp. 296–299, 2010.
View at: Publisher Site | Google Scholar
N. Kara, N. Sayin, D. Pirhan et al., “Evaluation of subfoveal choroidal thickness in pregnant women using enhanced depth imaging optical coherence tomography,” Current Eye Research, vol. 39, no. 6, pp. 642–647, 2014.
View at: Publisher Site | Google Scholar
M. Arab, M. Entezari, H. Ghamary et al., “Peripapillary retinal nerve fiber layer thickness in preeclampsia and eclampsia,” International Ophthalmology, vol. 38, no. 6, pp. 2289–2294, 2018.
View at: Publisher Site | Google Scholar
M.-H. Errera, R. P. Kohly, and L. da Cruz, “Pregnancy-associated retinal diseases and their management,” Survey of Ophthalmology, vol. 58, no. 2, pp. 127–142, 2013.
View at: Publisher Site | Google Scholar
R. A. Irani, Y. Zhang, C. C. Zhou et al., “Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling,” Hypertension, vol. 55, no. 5, pp. 1246–1253, 2010.
View at: Publisher Site | Google Scholar
P. Lichtlen, T. T. Lam, T. M. Nork, T. Streit, and D. M. Urech, “Relative contribution of VEGF and TNF-α in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105,” Investigative Opthalmology & Visual Science, vol. 51, no. 9, pp. 4738–4745, 2010.
View at: Publisher Site | Google Scholar
N. Reichhart, N. Haase, S. Crespo-Garcia et al., “Hypertensive retinopathy in a transgenic angiotensin-based model,” Clinical Science, vol. 130, no. 13, pp. 1075–1088, 2016.
View at: Publisher Site | Google Scholar
M. Saito, A. Ishibazawa, R. Kinouchi, and A. Yoshida, “Reperfusion of the choriocapillaris observed using optical coherence tomography angiography in hypertensive choroidopathy,” International Ophthalmology, vol. 38, no. 5, pp. 2205–2210, 2018.
View at: Publisher Site | Google Scholar
A. A. AlTalbishi, S. Khateb, and R. Amer, “Elschnig’s spots in the acute and remission stages in preeclampsia: spectral-domain optical coherence tomographic features,” European Journal of Ophthalmology, vol. 25, no. 5, pp. e84–e87, 2015.
View at: Publisher Site | Google Scholar
A. Thorsrud and E. Kerty, “Combined retinal and cerebral changes in a pre-eclamptic woman,” Acta Ophthalmologica, vol. 87, no. 8, pp. 925-926, 2009.
View at: Publisher Site | Google Scholar
M. Morikawa, K. Cho, T. Kojima et al., “Risk factors for central serous chorioretinopathy in pregnant Japanese women,” Journal of Obstetrics and Gynaecology Research, vol. 43, no. 5, pp. 866–872, 2017.
View at: Publisher Site | Google Scholar
L. M. Amaral, M. W. Cunningham Jr., D. C. Cornelius, and B. LaMarca, “Preeclampsia: long-term consequences for vascular health,” Vascular Health and Risk Management, vol. 11, pp. 403–415, 2015.
View at: Publisher Site | Google Scholar
D. Williams, “Pre-eclampsia and long-term maternal health,” Obstetric Medicine, vol. 5, no. 3, pp. 98–104, 2012.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Xinyi He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1199

Downloads

850

Citations